» Articles » PMID: 36561210

A Novel Vascular Health Index: Using Data Analytics and Population Health to Facilitate Mechanistic Modeling of Microvascular Status

Overview
Journal Front Physiol
Date 2022 Dec 23
PMID 36561210
Authors
Affiliations
Soon will be listed here.
Abstract

The study of vascular function across conditions has been an intensive area of investigation for many years. While these efforts have revealed many factors contributing to vascular health, challenges remain for integrating results across research groups, animal models, and experimental conditions to understand integrated vascular function. As such, the insights attained in clinical/population research from linking datasets, have not been fully realized in the basic sciences, thus frustrating advanced analytics and complex modeling. To achieve comparable advances, we must address the conceptual challenge of defining/measuring integrated vascular function and the technical challenge of combining data across conditions, models, and groups. Here, we describe an approach to establish and validate a composite metric of vascular function by comparing parameters of vascular function in metabolic disease (the obese Zucker rat) to the same parameters in age-matched, "healthy" conditions, resulting in a common outcome measure which we term the vascular health index (VHI). VHI allows for the integration of datasets, thus expanding sample size and permitting advanced modeling to gain insight into the development of peripheral and cerebral vascular dysfunction. Markers of vascular reactivity, vascular wall mechanics, and microvascular network density are integrated in the VHI. We provide a detailed presentation of the development of the VHI and provide multiple measures to assess face, content, criterion, and discriminant validity of the metric. Our results demonstrate how the VHI captures multiple indices of dysfunction in the skeletal muscle and cerebral vasculature with metabolic disease and provide context for an integrated understanding of vascular health under challenged conditions.

Citing Articles

Application of a novel index for understanding vascular health following pharmacological intervention in a pre-clinical model of metabolic disease.

Menon N, Halvorson B, Alimorad G, Frisbee J, Lizotte D, Ward A Front Pharmacol. 2023; 14:1104568.

PMID: 36762103 PMC: 9905672. DOI: 10.3389/fphar.2023.1104568.

References
1.
Imig J . Eicosanoid blood vessel regulation in physiological and pathological states. Clin Sci (Lond). 2020; 134(20):2707-2727. DOI: 10.1042/CS20191209. View

2.
Chantler P, Shrader C, Tabone L, dAudiffret A, Huseynova K, Brooks S . Cerebral Cortical Microvascular Rarefaction in Metabolic Syndrome is Dependent on Insulin Resistance and Loss of Nitric Oxide Bioavailability. Microcirculation. 2015; 22(6):435-45. PMC: 4551443. DOI: 10.1111/micc.12209. View

3.
Frisbee J, Goodwill A, Frisbee S, Butcher J, Brock R, Olfert I . Distinct temporal phases of microvascular rarefaction in skeletal muscle of obese Zucker rats. Am J Physiol Heart Circ Physiol. 2014; 307(12):H1714-28. PMC: 4269700. DOI: 10.1152/ajpheart.00605.2014. View

4.
Greene A, Lombard J, Cowley Jr A, Hansen-Smith F . Microvessel changes in hypertension measured by Griffonia simplicifolia I lectin. Hypertension. 1990; 15(6 Pt 2):779-83. DOI: 10.1161/01.hyp.15.6.779. View

5.
Laurent S, Agabiti-Rosei C, Bruno R, Rizzoni D . Microcirculation and Macrocirculation in Hypertension: A Dangerous Cross-Link?. Hypertension. 2022; 79(3):479-490. DOI: 10.1161/HYPERTENSIONAHA.121.17962. View